Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-021423
Filing Date
2024-02-27
Accepted
2024-02-27 17:23:29
Documents
128
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mnkd-20231231.htm   iXBRL 10-K 3890925
2 EX-4.3 mnkd-ex4_3.htm EX-4.3 27565
3 EX-10.4 mnkd-ex10_4.htm EX-10.4 22932
4 EX-10.6 mnkd-ex10_6.htm EX-10.6 27706
5 EX-10.29 mnkd-ex10_29.htm EX-10.29 538536
6 EX-23.1 mnkd-ex23_1.htm EX-23.1 3121
7 EX-31.1 mnkd-ex31_1.htm EX-31.1 10996
8 EX-31.2 mnkd-ex31_2.htm EX-31.2 10974
9 EX-32.1 mnkd-ex32_1.htm EX-32.1 7038
10 EX-32.2 mnkd-ex32_2.htm EX-32.2 7030
11 EX-97 mnkd-ex97.htm EX-97 46153
12 GRAPHIC img30090097_0.jpg GRAPHIC 67458
  Complete submission text file 0000950170-24-021423.txt   19218320

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20231231.xsd EX-101.SCH 2978284
130 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20231231_htm.xml XML 3438172
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50865 | Film No.: 24688688
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)